Margaret Ingels Allred
Novartis Gene Therapies
Margaret Ingels Allred is listed at Novartis Gene Therapies. Margaret is scheduled to speak at American Physical Therapy Association Annual on 5 February 2027.
Compiled from published conference agendas; not yet confirmed by Margaret. Is this you? Claim this profile.
About
Peggy Allred, PT, DPT, is a Senior Director of Translational Medicine at Novartis, where she provides strategic leadership for early development programs in adult and pediatric neuromuscular and neurodegenerative diseases. She brings more than three decades of experience spanning clinical practice, academic research, and pharmaceutical drug development, with deep expertise in functional endpoint selection, clinical trial design, rare disease natural history, and integration of digital health technologies, including wearables and remote assessments across multiple therapeutic modalities, including gene therapy, biologics, small molecules, and medical devices. Prior to joining Novartis, Dr. Allred held senior research and leadership roles at Cedars‑Sinai Medical Center, Washington University in St. Louis, and Baylor College of Medicine. She has presented extensively at national and international scientific and professional meetings, and her work has resulted in multiple peer-reviewed pub
Upcoming
American Physical Therapy Association Annual 4 February 2027 – 6 February 2027
- Physical Therapists Needed! from Movement Science to Drug Development: Expanding Our Professional Roles Speaker · 5 February 2027
Spoke alongside
People who have shared a session with Margaret at events on B2DB.
- Catherine Siener 1 shared session
- Kristin Ann Schmidt 1 shared session
- Trinh Tina Trung Duong Stanford University Medical Center 1 shared session